ストックスクリーナーアプリを入手
0.4749
0.04%
0.0002
Anebulo Pharmaceuticals Inc (ANEB) 最新ニュース
Dated alert on Anebulo Pharmaceuticals' voluntary delisting from Nasdaq withdrawn - marketscreener.com
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates - Yahoo Finance UK
Anebulo Pharmaceuticals to delist from Nasdaq, deregister with SEC By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SE - PharmiWeb.com
Anebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plans By Investing.com - Investing.com Nigeria
Anebulo Pharmaceuticals stock plunges after announcing Nasdaq delisting plans - Investing.com
Anebulo Pharmaceuticals Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Anebulo Pharmaceuticals to delist from Nasdaq, deregister with SEC - Investing.com
Anebulo Pharmaceuticals announces intention to voluntarily delist from Nasdaq and deregister with SEC - marketscreener.com
Anebulo Pharmaceuticals Announces Intention To Voluntarily Delist From Nasdaq And Deregister With SEC - TradingView
Anebulo Pharmaceuticals Announces Intention to Voluntarily Delist from Nasdaq and Deregister with SEC - Business Wire
Anebulo Pharmaceuticals (NASDAQ:ANEB) Trading Down 13.6% – What’s Next? - Defense World
Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock Price Down 13.6% – What’s Next? - Defense World
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Anebulo Pharmaceuticals Completes Oversubscribed Share Repurchase Tender - TipRanks
Anebulo Pharmaceuticals Announces Final Results of Tender Offer - TradingView
Investors tender 4.9M Anebulo shares, only 300,000 accepted at $3.50 - Stock Titan
Anebulo Pharmaceuticals Announces Oversubscribed Self-Tender Offer Results - TipRanks
Anebulo completes oversubscribed share repurchase tender offer - Investing.com
Anebulo Pharmaceuticals Announces Preliminary Tender Offer Results - TradingView
Nearly 4.9M shares chase Anebulo’s $3.50 self-tender - Stock Titan
Anebulo completes oversubscribed share repurchase tender offer By Investing.com - Investing.com UK
Anebulo Pharmaceuticals launches self-tender offer to go private - MSN
How Do Investors Really Feel About Anebulo Pharmaceuticals Inc? - Benzinga
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Down 41.3% in December - Defense World
Dip Buying: Can Anebulo Pharmaceuticals Inc stock hit analyst price targetsJuly 2025 Institutional & Community Verified Watchlist Alerts - Bộ Nội Vụ
Meme Stocks: Will Anebulo Pharmaceuticals Inc stock maintain momentum in 2025July 2025 Highlights & Weekly Stock Breakout Alerts - Bộ Nội Vụ
Valuation Update: Can Anebulo Pharmaceuticals Inc withstand a market correctionJuly 2025 Sentiment & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Published on: 2026-01-12 22:22:11 - Улправда
Trading Recap: Will Anebulo Pharmaceuticals Inc stock attract more institutional investorsBuy Signal & Fast Exit Strategy with Risk Control - moha.gov.vn
Will Anebulo Pharmaceuticals Inc. stock deliver shareholder valueQuarterly Portfolio Review & Daily Growth Stock Tips - ulpravda.ru
Will Anebulo Pharmaceuticals Inc. stock attract more institutional investorsCushioning Options Review & lightweight options for faster days - Улправда
Why Anebulo Pharmaceuticals Inc. stock is favored by top institutionsMarket Sentiment Report & Community Consensus Picks - Улправда
Will Anebulo Pharmaceuticals Inc. stock recover faster than peersJuly 2025 Spike Watch & Stepwise Swing Trade Plans - ulpravda.ru
EPS Watch: Will Anebulo Pharmaceuticals Inc. stock attract more institutional investorsPortfolio Gains Summary & Free Technical Confirmation Trade Alerts - Улправда
Why retail investors pile into Anebulo Pharmaceuticals Inc. stockHigh Beta Stocks & High Return Trading Tips - Улправда
Trend Review: Why Anebulo Pharmaceuticals Inc stock could outperform in 2025Market Weekly Review & Safe Capital Allocation Plans - Bộ Nội Vụ
Mereo BioPharma Group (NASDAQ:MREO) & Anebulo Pharmaceuticals (NASDAQ:ANEB) Financial Comparison - Defense World
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aug Technicals: What valuation multiples suggest for Anebulo Pharmaceuticals Inc stock2025 Historical Comparison & Safe Entry Momentum Tips - moha.gov.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
How Is The Market Feeling About Anebulo Pharmaceuticals Inc? - Benzinga
We're Hopeful That Anebulo Pharmaceuticals (NASDAQ:ANEB) Will Use Its Cash Wisely - Sahm
Anebulo shifts from reverse stock split to tender offer in go-private plan - Investing.com Nigeria
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Anebulo Pharmaceuticals stock plunges after scrapping reverse split plan By Investing.com - Investing.com South Africa
Anebulo Pharmaceuticals stock plunges after scrapping reverse split plan - Investing.com India
US Stocks Higher; Nasdaq Surges Over 100 Points - Benzinga
Anebulo Pharmaceuticals Launches Self-Tender Offer to Go Private - TipRanks
Anebulo shifts from reverse stock split to tender offer in go-private plan By Investing.com - Investing.com South Africa
Anebulo Pharmaceuticals, Inc. announces an Equity Buyback for 300,000 shares, representing 0.73% for $1.05 million. - MarketScreener
Anebulo Pharmaceuticals Announces Self Tender Offer to Go Private - TradingView — Track All Markets
Drug developer drops reverse split, plans cash buyback to go private - Stock Titan
Is Anebulo Pharmaceuticals Inc. stock affected by interest rate hikesJuly 2025 Selloffs & Low Risk Growth Stock Ideas - Улправда
Anebulo Pharmaceuticals, Inc. authorizes a Buyback Plan. - MarketScreener
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):